Cargando…

Dexmedetomidine protects against renal ischemia and reperfusion injury by inhibiting the JAK/STAT signaling activation

BACKGROUND: The α(2)-adrenoreceptor agonist dexmedetomidine is known to provide renoprotection against ischemia and reperfusion (I/R) injury. However the underlying molecular mechanisms remain unclear. The purpose of this study was to investigate whether the Janus kinase and signal transducer and ac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Si, Yanna, Bao, Hongguang, Han, Liu, Shi, Hongwei, Zhang, Yuan, Xu, Li, Liu, Chenhui, Wang, Jinsong, Yang, Xiaobing, Vohra, Akbar, Ma, Daqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3700850/ https://www.ncbi.nlm.nih.gov/pubmed/23759023 http://dx.doi.org/10.1186/1479-5876-11-141

Ejemplares similares

Dexmedetomidine Acts via the JAK2/STAT3 Pathway to Attenuate Isoflurane-Induced Neurocognitive Deficits in Senile Mice
por: Si, Yanna, et al.
Publicado: (2016)

Dexmedetomidine pretreatment alleviates cerebral ischemia/reperfusion injury by inhibiting neuroinflammation through the JAK2/STAT3 pathway
por: Liu, Huan, et al.
Publicado: (2022)

Osthole decreases renal ischemia-reperfusion injury by suppressing JAK2/STAT3 signaling activation
por: Luo, Lin-Na, et al.
Publicado: (2016)

Dexmedetomidine Pretreatment Protects Against Myocardial Ischemia/Reperfusion Injury by Activating STAT3 Signaling
por: Chen, Zhao-Rong, et al.
Publicado: (2023)

Cyanidin-3-O-glucoside plays a protective role against renal ischemia/ reperfusion injury via the JAK/STAT pathway
por: Xiong, Yufeng, et al.
Publicado: (2023)

Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice
por: Gu, Jianteng, et al.
Publicado: (2011)

Dexmedetomidine Protects against Ischemia and Reperfusion-Induced Kidney Injury in Rats
por: Bao, Naren, et al.
Publicado: (2020)

Protective Effects of Dexmedetomidine and Oxycodone in Patients Undergoing Limb Ischemia-Reperfusion
por: Cheng, Wenjie, et al.
Publicado: (2019)

Effect of dexmedetomidine on lung ischemia-reperfusion injury
por: JIANG, LILI, et al.
Publicado: (2014)

Sevoflurane postconditioning protects the myocardium against ischemia/reperfusion injury via activation of the JAK2–STAT3 pathway
por: Wu, Jianjiang, et al.
Publicado: (2017)

Inhibition of cerebral ischemia/reperfusion injury-induced apoptosis: nicotiflorin and JAK2/STAT3 pathway
por: Hu, Guang-qiang, et al.
Publicado: (2017)

Hydroxysafflor Yellow A mitigated myocardial ischemia/reperfusion injury by inhibiting the activation of the JAK2/STAT1 pathway
por: Zhou, Donglai, et al.
Publicado: (2019)

Dexmedetomidine Preconditioning Protects Rats from Renal Ischemia–Reperfusion Injury Accompanied with Biphasic Changes of Nuclear Factor-Kappa B Signaling
por: Bao, Naren, et al.
Publicado: (2020)

Effects of dexmedetomidine on renal microcirculation in ischemia/reperfusion-induced acute kidney injury in rats
por: Yang, Szu-Jen, et al.
Publicado: (2021)

The Protective Effect of Magnesium Lithospermate B on Hepatic Ischemia/Reperfusion via Inhibiting the Jak2/Stat3 Signaling Pathway
por: Zhang, Ning, et al.
Publicado: (2019)

Protective effects of N(2)-L-alanyl-L-glutamine mediated by the JAK2/STAT3 signaling pathway on myocardial ischemia reperfusion
por: Liu, Shan, et al.
Publicado: (2018)

Dexmedetomidine preconditioning ameliorates kidney ischemia-reperfusion injury
por: Lempiäinen, Juha, et al.
Publicado: (2014)

The Application and Analytical Pathway of Dexmedetomidine in Ischemia/Reperfusion Injury
por: Tang, Ying, et al.
Publicado: (2019)

Does remifentanil attenuate renal ischemia–reperfusion injury better than dexmedetomidine in rat kidney?
por: Erkılıç, E, et al.
Publicado: (2017)

Edaravone alleviates cell apoptosis and mitochondrial injury in ischemia–reperfusion-induced kidney injury via the JAK/STAT pathway
por: Zhao, Xiaoying, et al.
Publicado: (2020)

Irisin Contributes to the Hepatoprotection of Dexmedetomidine during Intestinal Ischemia/Reperfusion
por: Fan, Xin, et al.
Publicado: (2019)

Evolving spectrum of dexmedetomidine preconditioning for Ischemia–reperfusion injury amelioration
por: Kohli, Jasvinder K., et al.
Publicado: (2020)

Hydrogen sulfide postconditioning protects isolated rat hearts against ischemia and reperfusion injury mediated by the JAK2/STAT3 survival pathway
por: Luan, Heng-Fei, et al.
Publicado: (2012)

The JAK2/STAT3 pathway is involved in dexmedetomidine-induced myocardial protection in rats undergoing cardiopulmonary bypass
por: Pan, Sining, et al.
Publicado: (2020)

Effect of trimetazidine against ovarian ischemia/reperfusion injury in rat model: A new pathway: JAK2/STAT3
por: Yuksel, Tugba Nurcan, et al.
Publicado: (2023)

SHP-1/STAT3 Interaction Is Related to Luteolin-Induced Myocardial Ischemia Protection
por: Liu, Donghai, et al.
Publicado: (2021)

Eriodictyol Attenuates Myocardial Ischemia-Reperfusion Injury through the Activation of JAK2
por: Li, Defang, et al.
Publicado: (2018)

LINGO-1 shRNA protects the brain against ischemia/reperfusion injury by inhibiting the activation of NF-κB and JAK2/STAT3
por: Zhu, Jiaying, et al.
Publicado: (2021)

Effect of dexmedetomidine pretreatment on lung injury following intestinal ischemia-reperfusion
por: SHEN, JINMEI, et al.
Publicado: (2013)

Effects of dexmedetomidine on renal tissue after lower limb ischemia reperfusion injury in streptozotocin induced diabetic rats
por: Erbatur, Meral Erdal, et al.
Publicado: (2017)

The role of JAK/STAT signaling pathway in cerebral ischemia-reperfusion injury and the therapeutic effect of traditional Chinese medicine: A narrative review
por: Song, Tianzhi, et al.
Publicado: (2023)

Dexmedetomidine preconditioning protects against lung injury induced by ischemia-reperfusion through inhibition of autophagy
por: Zhang, Wei, et al.
Publicado: (2017)

Ischemia-Reperfusion Injury Reduces Long Term Renal Graft Survival: Mechanism and Beyond
por: Zhao, Hailin, et al.
Publicado: (2018)

Protective Effect of Stachydrine Against Cerebral Ischemia-Reperfusion Injury by Reducing Inflammation and Apoptosis Through P65 and JAK2/STAT3 Signaling Pathway
por: Li, Li, et al.
Publicado: (2020)

Empagliflozin protects against renal ischemia/reperfusion injury in mice
por: Wang, Qifeng, et al.
Publicado: (2022)

Dexmedetomidine Attenuates Ferroptosis-Mediated Renal Ischemia/Reperfusion Injury and Inflammation by Inhibiting ACSL4 via α2-AR
por: Tao, Wen-hui, et al.
Publicado: (2022)

The preventive effects of dexmedetomidine against intestinal ischemia-reperfusion injury in Wistar rats
por: Zhang, Xue-kang, et al.
Publicado: (2015)

The effect of dexmedetomidine on gastric ischemia reperfusion injury in rats. Biochemical and histopathological evaluation
por: Kuyrukluyildiz, Ufuk, et al.
Publicado: (2021)

Dexmedetomidine enables copper homeostasis in cerebral ischemia/reperfusion via ferredoxin 1
por: Guo, Qingduo, et al.
Publicado: (2023)

Meprin β expression modulates the interleukin‐6 mediated JAK2‐STAT3 signaling pathway in ischemia/reperfusion‐induced kidney injury
por: Abousaad, Shaymaa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0vhcijgfdtvaudksuaj031hshf